Braxia Scientific Corp. (BRAXF)

USD 0.0

(21.43%)

Eps Summary of Braxia Scientific Corp.

  • Braxia Scientific Corp.'s latest annual eps in 2023 was -0.06 CAD , up 16.91% from previous year.
  • Braxia Scientific Corp.'s latest quarterly eps in 2024 Q3 was -0.00 CAD , down -240.0% from previous quarter.
  • Braxia Scientific Corp. reported an annual eps of -0.07 CAD in 2022, up 87.64% from previous year.
  • Braxia Scientific Corp. reported an annual eps of -0.56 CAD in 2021, down -12627.27% from previous year.
  • Braxia Scientific Corp. reported a quarterly eps of -0.00 CAD for 2024 Q3, down -240.0% from previous quarter.
  • Braxia Scientific Corp. reported a quarterly eps of -0.00 CAD for 2024 Q2, up 66.67% from previous quarter.

Annual Eps Chart of Braxia Scientific Corp. (2023 - 2020)

Historical Annual Eps of Braxia Scientific Corp. (2023 - 2020)

Year Eps Eps Growth
2023 -0.06 CAD 16.91%
2022 -0.07 CAD 87.64%
2021 -0.56 CAD -12627.27%
2020 -0.00 CAD 0.0%

Peer Eps Comparison of Braxia Scientific Corp.

Name Eps Eps Difference
Bioxytran, Inc. -0.03 USD -80.251%
Eiger BioPharmaceuticals, Inc. -50.78 USD 99.887%
Institute of Biomedical Research Corp. -0.05 USD -11.65%
SQZ Biotechnologies Company -2.76 USD 97.917%
Intellipharmaceutics International Inc. -0.09 USD 34.211%
Evofem Biosciences, Inc. 10.35 USD 100.556%
Santhera Pharmaceuticals Holding AG 5.95 USD 100.966%
Propanc Biopharma, Inc. -0.02 USD -142.616%
Marizyme, Inc. -1.44 USD 96.007%
Genus plc 0.12 USD 147.917%
Pharming Group N.V. -0.02 USD -257.143%
Therapeutic Solutions International, Inc. -0.00 USD -8114.286%
CNBX Pharmaceuticals Inc. -0.42 USD 86.31%
Nymox Pharmaceutical Corporation -0.10 USD 40.415%
ContraFect Corporation -124.97 USD 99.954%
RegeneRx Biopharmaceuticals, Inc. -0.01 USD -379.167%
IMV Inc. -4.37 USD 98.684%
AXIM Biotechnologies, Inc. -0.04 USD -62.429%
ONE Bio Corp. 1.43 USD 104.021%
RVL Pharmaceuticals plc -0.58 USD 90.086%
Mesoblast Limited -0.09 USD 35.466%
MultiCell Technologies, Inc. -0.00 USD -57400.0%
Arno Therapeutics, Inc. - USD Infinity%
Emmaus Life Sciences, Inc. -0.07 USD 18.208%
Genscript Biotech Corporation -0.05 USD -26.652%
Neon Bloom, Inc. -0.00 USD -3733.333%
Mosaic ImmunoEngineering Inc. -0.33 USD 82.576%
Nanobac Pharmaceuticals, Incorporated - USD Infinity%
Biomind Labs Inc. -0.02 USD -254.938%
Provectus Biopharmaceuticals, Inc. -0.01 USD -677.027%
Oncotelic Therapeutics, Inc. -0.02 USD -188.945%
Skye Bioscience, Inc. -5.37 USD 98.929%
GlobeStar Therapeutics Corporation -0.00 USD -2295.833%
VioQuest Pharmaceuticals, Inc. -2.33 USD 97.532%
THC Farmaceuticals, Inc. -0.00 USD -7087.5%
PsyBio Therapeutics Corp. -0.04 USD -36.905%
Arch Therapeutics, Inc. -2.27 USD 97.467%
Sienna Biopharmaceuticals, Inc. - USD Infinity%
Acro Biomedical Co., Ltd. -0.26 USD 77.885%
Accustem Sciences Inc. -0.34 USD 83.088%
EV Biologics, Inc. -0.12 USD 52.083%
Q BioMed Inc. -0.08 USD 26.376%
GB Sciences, Inc. -0.00 USD -1302.439%
Alpha Cognition Inc. -0.15 USD 61.667%
CSL Limited 2.73 USD 102.106%
Agentix Corp. -0.04 USD -64.286%
American Oriental Bioengineering, Inc. -781.24 USD 99.993%
Enzolytics Inc. -0.00 USD -8114.286%
TetraLogic Pharmaceuticals Corporation - USD Infinity%
Resverlogix Corp. -0.01 USD -304.93%
Nuo Therapeutics, Inc. -0.08 USD 23.74%
MetaStat, Inc. - USD Infinity%
Curative Biotechnology, Inc. -0.01 USD -553.409%
argenx SE -5.16 USD 98.886%
Northwest Biotherapeutics, Inc. -0.06 USD -0.0%
HST Global, Inc. -0.03 USD -106.093%
Enzon Pharmaceuticals, Inc. 0.00 USD 4523.077%
Wesana Health Holdings Inc. -0.05 USD -14.77%
Halberd Corporation -0.00 USD -57400.0%
Endonovo Therapeutics, Inc. 0.03 USD 329.084%
Inhibitor Therapeutics, Inc. -0.02 USD -187.5%
Zenith Capital Corp. -0.07 USD 17.74%
RespireRx Pharmaceuticals Inc. -0.04 USD -61.064%
GeneThera, Inc. - USD Infinity%
Sigyn Therapeutics, Inc. -3.77 USD 98.475%
AVAX Technologies, Inc. -0.05 USD -6.679%
WPD Pharmaceuticals Inc. -0.00 USD -11400.0%
Cotinga Pharmaceuticals Inc. -0.09 USD 37.021%
Ember Therapeutics, Inc. -0.01 USD -812.698%
Anthera Pharmaceuticals, Inc. - USD Infinity%
Adynxx, Inc. - USD Infinity%
NovAccess Global Inc. -0.23 USD 75.0%
Helix BioMedix, Inc. -4.70 USD 98.777%
Capstone Therapeutics Corp. -36.39 USD 99.842%
Kadimastem Ltd -0.78 USD 92.628%
VitaSpring Biomedical Co. Ltd. - USD Infinity%
BioStem Technologies, Inc. -0.62 USD 90.726%
Oncology Pharma Inc. - USD Infinity%
Reve Technologies, Inc. -0.01 USD -383.193%
Burzynski Research Institute, Inc. -0.01 USD -463.725%
LadRx Corporation 0.68 USD 108.456%
Cell Source, Inc. -0.17 USD 66.176%
ProtoKinetix, Incorporated -0.01 USD -475.0%
Regen BioPharma, Inc. 0.29 USD 119.828%
Regen BioPharma, Inc. 0.26 USD 122.115%
Affymax, Inc. -0.39 USD 85.256%
Mobile Lads Corp. -0.01 USD -926.786%
Itoco Inc. -0.01 USD -656.579%
Rasna Therapeutics, Inc. -0.01 USD -475.0%
Pathfinder Cell Therapy, Inc. -0.00 USD -2200.0%
International Stem Cell Corporation -0.02 USD -250.61%
CytoDyn Inc. -0.05 USD -8.696%
Claritas Pharmaceuticals, Inc. - USD Infinity%
NDT Pharmaceuticals Inc. -0.00 USD -11400.0%
NanoSphere Health Sciences Inc. -0.02 USD -159.009%
Qrons Inc. -0.06 USD 1.372%
Alseres Pharmaceuticals, Inc. -153.67 USD 99.963%
SYBLEU INC -0.02 USD -228.571%
Advanced Proteome Therapeutics Corporation - USD Infinity%
Nascent Biotech, Inc. -0.01 USD -329.104%
Rebus Holdings, Inc. -0.03 USD -79.128%
GlobeImmune, Inc. - USD Infinity%
ImmunoCellular Therapeutics, Ltd. -0.01 USD -304.93%
Predictive Technology Group, Inc. - USD Infinity%
ProText Mobility, Inc. - USD Infinity%
Cardax, Inc. - USD Infinity%
VG Life Sciences Inc. -0.00 USD -57400.0%
Kaleido Biosciences, Inc. - USD Infinity%
Advaxis, Inc. -7.99 USD 99.28%
Adhera Therapeutics, Inc. -1.18 USD 95.127%
RenovaCare, Inc. - USD Infinity%
Regnum Corp. -0.03 USD -69.118%
Innovation Pharmaceuticals Inc. -0.01 USD -812.698%
Neutra Corp. -0.00 USD -57400.0%
Windtree Therapeutics, Inc. -94.23 USD 99.939%
PureTech Health plc -2.38 USD 97.584%
Coeptis Therapeutics, Inc. -0.83 USD 93.072%
IXICO plc -0.02 USD -135.656%
IntelGenx Technologies Corp. -0.06 USD -1.232%
Gelesis Holdings, Inc. -1.35 USD 95.741%
CSL Limited 5.47 USD 101.051%
Cellectis S.A. -1.77 USD 96.751%